Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2

Neuroscience

• Mitogen-Activated Protein Kinase 100%
• Western Blot 66%
• Alternative Complement Pathway C3 C5 Convertase 66%
• Nuclear Factor 66%
• Brain-Computer Interface 66%
• Protein 33%
• Kinase 33%
• Cell Signaling 33%
• Neuron 33%
• Phosphorylation 33%
• Brain Injury 33%
• Brain 33%
• Ischemic Stroke 33%
• Immunofluorescence 33%
• Apoptosis 33%
• Nitric Oxide 33%
• Amino Terminal Sequence 33%
• Extracellular Signal-Regulated Kinases 33%
• P38 Mitogen-Activated Protein Kinases 33%
• Myeloperoxidase 33%
• Transcription Factor Nrf2 33%